PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27902462-8 2016 We show that PARP1 silencing or inhibition (BMN673 or Olaparib) leads to selective killing within RAD54B-deficient cells relative to controls, and is accompanied by increases in gamma-H2AX (a surrogate marker of DNA double strand breaks) and cleaved Caspase-3 (an apoptotic indicator). olaparib 54-62 caspase 3 Homo sapiens 250-259 25139258-5 2015 In vitro, the combination with olaparib exacerbates the appearance of cell death markers, such as Annexin V positivity, caspase 3 cleavage, cytochrome C release and propidium iodide permeability. olaparib 31-39 caspase 3 Homo sapiens 120-129 35163965-5 2022 Treatment of MCF-7 cells with compounds 5u and 5s produced PARP cleavage, H2AX phosphorylation and CASPASE-3 activation comparable to that observed with Olaparib. olaparib 153-161 caspase 3 Homo sapiens 99-108 24826054-9 2014 Pro-caspase-3 and PARP degradation was induced by paclitaxel and enhanced by olaparib in a dose-dependent manner. olaparib 77-85 caspase 3 Homo sapiens 0-13 34969765-5 2022 RESULTS: Olaparib decreased the cell viability of EBV-positive SNU719 gastric cancer cells through caspase-3-dependent apoptosis in a dose dependent manner, whereas EBV-negative SNU638 gastric cancer cells showed drug resistance to olaparib. olaparib 9-17 caspase 3 Homo sapiens 99-108 34969765-5 2022 RESULTS: Olaparib decreased the cell viability of EBV-positive SNU719 gastric cancer cells through caspase-3-dependent apoptosis in a dose dependent manner, whereas EBV-negative SNU638 gastric cancer cells showed drug resistance to olaparib. olaparib 232-240 caspase 3 Homo sapiens 99-108 32276472-5 2020 Compared with the limited effect of single-agent olaparib (PARP inhibitor) or PD173074 on PANC-1 and SUIT-2 cells, low-dose combination (olaparib + PD173074) treatment significantly, dose-dependently, and synergistically reduced cell viability, upregulated cleaved PARP, pro-caspase (CASP)-9, cleaved-CASP9, and cleaved-CASP3 protein expression, and downregulated Bcl-xL protein expression. olaparib 137-145 caspase 3 Homo sapiens 320-325